Align Technology, Inc. $ALGN Stock Sold by Factory Mutual Insurance Co.

Align Technology logo with Healthcare background
Image from MarketBeat Media, LLC.

Key Points

  • Factory Mutual Insurance Co. cut its Align Technology stake by 57.2% in the third quarter, selling 266,266 shares and retaining 198,957 shares worth about $28.9 million.
  • Other institutional investors added shares, including Assenagon, which increased its holdings by 638.7%; institutions collectively owned 88.43% of the company’s stock.
  • Align beat quarterly earnings and revenue estimates, reporting $2.80 EPS and $1.01 billion in revenue. Analysts’ consensus rating was “Moderate Buy,” with an average price target of $193.08.
  • Five stocks to consider instead of Align Technology.

Factory Mutual Insurance Co. lessened its holdings in Align Technology, Inc. (NASDAQ:ALGN - Free Report) by 57.2% in the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 198,957 shares of the medical equipment provider's stock after selling 266,266 shares during the period. Factory Mutual Insurance Co. owned about 0.28% of Align Technology worth $28,918,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also modified their holdings of the company. Assenagon Asset Management S.A. lifted its stake in Align Technology by 638.7% in the 3rd quarter. Assenagon Asset Management S.A. now owns 4,662,437 shares of the medical equipment provider's stock worth $629,469,000 after acquiring an additional 4,031,284 shares in the last quarter. BlackRock Inc. purchased a new position in Align Technology during the 2nd quarter valued at about $745,370,000. Loring Wolcott & Coolidge Fiduciary Advisors LLP MA grew its stake in Align Technology by 3,162.7% during the 3rd quarter. Loring Wolcott & Coolidge Fiduciary Advisors LLP MA now owns 2,097,745 shares of the medical equipment provider's stock valued at $278,342,000 after acquiring an additional 2,033,451 shares in the last quarter. Vontobel Holding Ltd. increased its holdings in shares of Align Technology by 69,628.9% in the 3rd quarter. Vontobel Holding Ltd. now owns 1,385,513 shares of the medical equipment provider's stock valued at $183,335,000 after purchasing an additional 1,383,526 shares during the period. Finally, Arrowstreet Capital Limited Partnership increased its holdings in shares of Align Technology by 4.9% in the 1st quarter. Arrowstreet Capital Limited Partnership now owns 1,054,633 shares of the medical equipment provider's stock valued at $180,796,000 after purchasing an additional 49,220 shares during the period. Hedge funds and other institutional investors own 88.43% of the company's stock.

Align Technology Price Performance

Shares of ALGN stock opened at $151.58 on Wednesday. Align Technology, Inc. has a fifty-two week low of $130.23 and a fifty-two week high of $200.43. The stock's 50-day moving average is $150.12 and its two-hundred day moving average is $168.59. The firm has a market cap of $10.86 billion, a P/E ratio of 16.52, a PEG ratio of 1.67 and a beta of 1.74.

Align Technology (NASDAQ:ALGN - Get Free Report) last posted its quarterly earnings results on Wednesday, October 28th. The medical equipment provider reported $2.80 earnings per share for the quarter, topping analysts' consensus estimates of $2.77 by $0.03. The company had revenue of $1.01 billion during the quarter, compared to the consensus estimate of $1 billion. Align Technology had a return on equity of 15.96% and a net margin of 11.83%. The business's quarterly revenue was up 1.9% on a year-over-year basis. During the same period last year, the business earned $2.61 EPS. As a group, research analysts expect that Align Technology, Inc. will post 9.19 EPS for the current year.

Wall Street Analysts Forecast Growth

ALGN has been the subject of a number of research analyst reports. Weiss Ratings raised shares of Align Technology from a "hold (c-)" rating to a "hold (c)" rating in a research report on Friday, October 9th. UBS Group reaffirmed a "neutral" rating and set a $189.00 price objective on shares of Align Technology in a research report on Thursday, July 23rd. Stifel Nicolaus dropped their price objective on shares of Align Technology from $210.00 to $175.00 and set a "buy" rating on the stock in a research note on Friday, October 9th. Wall Street Zen downgraded shares of Align Technology from a "buy" rating to a "hold" rating in a research report on Saturday, October 24th. Finally, Raymond James Financial reiterated a "buy" rating on shares of Align Technology in a research report on Monday, October 5th. One analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating, seven have assigned a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and a consensus target price of $193.08.

Get Our Latest Stock Analysis on Align Technology

About Align Technology

(Free Report)

Align Technology, Inc is a global medical device company focused on digital orthodontics and restorative dentistry. Founded in 1997, the company is best known for the Invisalign system, a series of clear, removable aligners designed to gradually move teeth and treat a range of orthodontic conditions.

Align's products and services also include digital scanning and dental practice solutions. Its iTero intraoral scanners create digital impressions for orthodontic and restorative procedures, while its exocad business develops computer-aided design and computer-aided manufacturing software used by dental laboratories, clinicians and other dental professionals.

The company serves orthodontists, dentists, dental laboratories and patients in numerous markets worldwide.

See Also

Want to see what other hedge funds are holding ALGN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Align Technology, Inc. (NASDAQ:ALGN - Free Report).

Institutional Ownership by Quarter for Align Technology (NASDAQ:ALGN)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Align Technology Right Now?

Before you consider Align Technology, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Align Technology wasn't on the list.

While Align Technology currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Energy Stocks to Buy and Hold Forever Cover

Oil still powers the global economy, but AI is reshaping the energy opportunity. Discover seven stocks spanning traditional energy, infrastructure, and next-generation power.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines